HOME- R&D
- Bryn Mawr Conference
- Hyderabad Conference
- Workshops & Training
- Program
- Drug Discovery Innovation
- Proteins
- Quantum Biochemistry
- Screening
- Web Services
- Abstracts
- Speakers
- Bender, A
- Bryant, S
- Coles, S
- Covell, D
- De Sousa, J
- Dimitropoulos, D
- Gasteiger, J
- Golovin, A
- Henrick, K
- Irwin, J
- Kel, A
- Krissinel, E
- Nicklaus, M
- Poroikov, V
- Rassokhin, D
- Schwede, T
- Pharmacophores
- Graph Mining
- Nanotech
- Membranes & Ion Channels
- Exhibition
- Registration
- Jobs
- Contact
- Schedule
|
|
|
|
|
|
|
| Vladimir Poroikov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci. |
|
Vladimir Vasilievich Poroikov (Poroykov)
Born: 1 August 1951, Krolevetz, Sumy Region, USSR
Married, three children.
EDUCATION:
M.Sc. in Physics (Department of Physics, Moscow State University, 1974).
SCIENTIFIC DEGREES:
Professor in Biochemistry (Institute of Biomedical Chemistry of Russian Academy of Medical Sciences, Moscow, 2000).
D.Sc. in Pharmacology. (National Research Center for Biologically Active Compounds, Staraya Kupavna, Moscow Region, 1995).
Ph.D. in Biophysics (Department of Biology, Moscow State University, 1981).
APPOINTMENTS:
Deputy Director (Research) in the Institute of Biomedical Chemistry of Russian Academy of Medical Sciences (IBMC, Moscow), since 1998.
Professor of Medical & Biological Faculty of Russian State Medical University, since 1996.
Head of Laboratory for Structure-Function Based Drug Design in the IBMC, since 1995.
1974-1995 National Research Center for Biologically Active Compounds (formerly - Research Institute for Biological Testing of Chemical Compounds, Staraya Kupavna, Moscow Region).
OTHER ACTIVITIES:
Vice-Chairman of the Russian Section of The QSAR and Modeling Society, since 1996; Member of the American Chemical Society (Cheminformatics Division), since 2002; Vice-Editor of Biomedical Chemistry (Rus.), Editorial Board Member of Russian Chemical & Pharmaceutical Journal; Co-Chairman of the Symposium "Bioinformatics and Computer-Aided Drug Discovery" (in 1995-1998 - "Computer-Aided Drug Design") at the annual Russian National Congresses "Man and Drugs", Moscow (1995-2003); Chairman of the Local Committee of the International Conference "Genomics, Proteomics and Bioinformatics for Medicine" (St.-Petersburg - Moscow, June 24-30, 2002); Scientific Advisory Board Member of the European Symposium on QSAR & Modelling (Euro-QSAR 2002), Bourthmouth, UK, September 2002; Scientific Advisory Board Member of the International Symposium on Drug Discovery and Process Research, Kolhapur, India, January 2003.
TEACHING EXPERIENCE:
Since 1996 Professor of Medical & Biological Faculty of Russian State Medical University. Special course "Bioinformatics and Computer-Aided Drug Discovery" for graduate students.
1997-2002: 8 PhD Students; 12 Graduate Students (work under my supervision).
AWARDS:
Medal "For scientific partnerships" (2001), Medal "850 years of Moscow" (1997), Gold Medal on School Graduation (1968).
PUBLICATIONS:
Co-author of more than 200 published works and 12 non-open published reports in R & D of new pharmaceuticals.
|
|
Computer-aided Prediction of Biological Activity Spectra as a way to creating new effective and safe medicines
Vladimir Poroikov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, 119121 Russia
Today the number of unique chemical compounds available for screening on a commercial basis is about twenty million. The number of potential pharmacological targets is quickly growing due to the achievements of "omic"-sciences and bioinformatics. Despite the development of new ultra-HTS technologies, a breach between the number of available compounds and ability to test them against all known targets is permanently increasing. By using computer prediction of biological activity spectra on the basis of accumulated information about targets and ligands, this breach can be reduced significantly. As a result, new knowledge about structure-activity relationships will be obtained for compounds under study, and the risk to miss useful pharmacological or dangerous adverse/toxic effects will be considerably decreased. We developed the computer program PASS (http://ibmc.msk.ru/PASS), which predicts more than 1000 kinds of biological activity on the basis of structural formula of chemical compounds with average accuracy ~85% (LOO CV). PASS predictions for ~250000 compounds from the open NCI database are available from the NCI web-site http://cactus.nci.nih.gov/ncidb2/. It was shown that application of PASS increases the number of active "hits" in the selected sub-set of compounds up to ~17 times [1]. Based on PASS predictions, new angiogenesis inhibitors [1], anxiolytics [2], cognition enhancers [3], antileishmanials [4], and other new biologically active compounds were found. The academic community may use PASS via the Internet for free, to estimate biological activity spectra of their compounds either already synthesized or virtually designed, or just planned for synthesis [5]. About 3000 researchers obtained the predicted biological activity spectra for ~ 50000 chemical compounds, which provided them criteria for selection of the most prospective "candidates".
1. Poroikov V.V., Filimonov D.A., Ihlenfeldt W.-D. etal. (2003). J. Chem. Inform. Comput. Sci., 43:228-236.
2. Geronikaki A., Babaev E., Dearden J. et al. (2004). Bioorg. Med.Chem., 12: 6559-6568.
3. Geronikaki A., Dearden J., Filimonov D. et al. (2004). J. Med. Chem., 47:2870-2876.
4. Di Giorgio C., Delmas F., Filloux N. et al. (2003). Antimicrobial Agents and Chemotherapy, 47: 174-180.
5. Sadym A., Lagunin A., Filimonov D., Poroikov V.(2003). SAR and QSAR in Environm. Res., 14:339-347.
|
|
|
|
|
|
|
|
|
